Theme: Leading Innovations and Remedial Insights into the Parkinsons Disease

Parkinsons 2016

Parkinsons 2016

Conferenceseries LLC organizes conference all around the world in 2016 here we welcome you to the 2ndInternational Conference on Parkinson’s Disease and Movement Disorders during December 05-07, 2016 at Phoenix, USA.

Parkinson’s disease is the 14th leading cause of death in the United States. The number of people in the United States with Parkinson’s disease is estimated to be as 1.5 million. Approximately 60,000 Americans are newly diagnosed each year. Some early-onset diagnoses are linked to specific gene mutations. Total risk for the disease is between 2 % and 5 % if no family members have a known gene mutation. About 15 % to 25 % of people with Parkinson’s have a relative with the disease.

Track 1: Epidemiology of Parkinsons disease

PD is the second most typical neurodegenerative disorder and manifests as bradykinesia, rigidity, posture instability and resting tremor. Although the disease symptomatology can be well controlled by levodopa, deep brain stimulation and related medications, the etiology of PD remains obscure. Estimated prevalence rates and costs were applied to the U.S. Census Bureaus from 2010 to 2050 population data to estimate current and projected burden based on changing demographics. We estimate approximately 630,000 people in the United States had diagnosed PD in 2010, with diagnosed prevalence will be double by 2040. The national economic burden of PD exceeds $14.4 billion in 2010. The population with Parkinson’s disease incurred medical expenses of approximately $14 billion in 2010, $8.1 billion higher than expected for a similar population without PD. Indirect costs is conservatively estimated at $6.3 billion.

Related Conferences Parkinsons Conferences | Parkinsons 2016 | Neurology Congress | Neurology 2016

6th World Neurological Conference May 19-21, 2016 San Antonio, USA, 2nd International Conference on Brain Disorders October 17-29, 2016 Chicago, USA, International Conference on Neuro Oncology and Brain Tumor July 21-22, 2016 Brisbane, Australia, 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery August 22-24, 2016 Vienna, Austria, 2ndInternational Conference on Sleep Disorders November 28-30, 2016 Chicago, USA 20th International Congress on Parkinson’s Disease and Movement Disorders June 19-23 2016, Berlin, Germany, 4th World Parkinson Coalition, Portland September 20-23, 2016, 11th International Congress on Non-Motor Dysfunctions in Parkinson’s disease and Related Disorders, Ljubljana, Slovenia, October 06-09, 2016, 5th Asian and Oceanian Parkinson’s Disease and Movement Disorders Congress, March 11–13, 2016, Manila, Philippines, Parkinson Action Network, February 29-March 2, 2016, Washington. Movement Disorders Society, Parkinson Society Canada, European Neurological Society, American Academy of Neurology, UK Parkinson's Action Network

 

Track 2: Neuromuscular Disorders

Neuromuscular disorders could be a general term that refers to diseases that affect any part of the nerve and muscle. These disorders vary consistent with characteristics like pattern of inheritance, origin of the genetic mutation, age of onset, symptoms, rate of progression, incidence and prognosis. Each year, 750,000 people in US experiences a stroke and 11,000 suffer a spinal cord injury. 500,000 Americans currently live with cerebral palsy, 270,000 with multiple sclerosis and 5.3 million with the after-effects of a traumatic brain injury, and thousands more with movement disorders like ALS, amyotrophic lateral sclerosis and other conditions that rob them of their ability to move their muscles and, in several cases, live independently.

Related Conferences Parkinsons Conference | Parkinsons 2016 | Neurology Congress | Neurology 2016

5th International Conference on Alzheimer’s Disease and Dementia September 29-Oct 1, 2016 London, UK, International Conference on Neuro Oncology and Brain Tumor July 21-22, 2016 Brisbane, Australia, 2nd International Conference on Brain Disorders and Therapeutics  October 17-29, 2016 Chicago, USA, 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery August 22-24, 2016 Vienna, Austria, 3rd Ottawa International Conference on Neuromuscular Biology, Disease and Therapy on September 24-26, 2015, American Association of Neuromuscular and Electro diagnostic Medicine 28-31 Oct 2015, Hawaii, USA, Neuromuscular Care Conference 23-24 Nov 2015, Nottingham, UK, 9th Annual Neuromuscular Translational Research Conference, 22-23 Mar 2016, Oxford, United Kingdom, Update in Neuromuscular disorders September 3-6 May 2016. Movement Disorders Society, Parkinson Society Canada, European Neurological Society, American Academy of Neurology, UK Parkinson's Action Network

 

Track 3: Neurocognitive Disorders

Neurocognitive disorder occurs possibly due to PD, with behavioral disturbance. Parkinson disease has staging system that can help to determine when the illness has become severely debilitating and end-of-life care. According to the United Nations projections, between the years 2000 to 2050 the number of individuals over 65 years of age will exceed 1.1 billion worldwide. In developed countries alone will increase from 13.5 million to 36.7 million. Cognitive function can be the most troubling symptoms in PD.

Related Conferences Parkinsons Conferences | Parkinsons 2016 | Neurology Congress | Neurology 2016

International Conference on Spine and Spinal Disorders June 30-July 2, 2016 Valencia, Spain, 2nd International Conference on Central Nervous System Disorders and Therapeutics December 1-2 2016 Dubai, UAE, International Conference on Neuro Oncology and Brain Tumor July 21-22, 2016 Brisbane, Australia, International Conference on Autism May 5-6, 2016 Chicago, USA, 6th World Neurological Conference May 19-21, 2016 San Antonio, USA, Myotonic Dystrophy Conference 19 Sep 2015, Nottingham, UK, 3rd International Conference on Heart and Brain February 25-27, 2016, Neuromuscular Care Conference 23 Nov 2015, Nottingham, The Eleventh World Congress on Brain Injury March 2-5, 2016, Netherlands, 9th Annual Neuromuscular Translational Research Conference, 22-23 Mar 2016, Oxford, United Kingdom, 18th International Conference on Cognitive Neuroscience January 21-22, 2016, Paris, France. Movement Disorders Society, Parkinson Society Canada, European Neurological Society, American Academy of Neurology, UK Parkinson's Action Network

 

Track 4: Risk factors for Parkinsons disease

The Parkinsons disease shows more than 75% will show signs of dementia and affects between .05%–1% of people aged 65–69 and 1%–3% over 80. More common in men than women, 25%–40% it is caused by loss of dopamine causes tremors and rigid movements. Dopamine is key to the control of movement. It can involve psychological symptoms like depression, anxiety, apathy, cognitive problems, hallucinations, and delusions.

Related Conferences Parkinsons Conferences | Parkinsons 2016 | Neurology Congress | Neurology 2016

2nd International Conference on  Depression, Anxiety and Stress Management November 3-4, 2016 Valencia, Spain, 2nd International Conference on Sleep Disorders and Medicine Conference November 28- 30, 2016 Chicago, USA, 4th International Conference on Vascular Dementia  June 30-July 2, 2016 Valencia, Spain, International Conference on Autism May 5-6, 2016 Chicago, USA, 20th International Congress on Parkinson’s Disease and Movement Disorders June 19-23 2016, Berlin, Germany, 4th World Parkinson Coalition, Portland September 20-23, 2016, 11th International Congress on Non-Motor Dysfunctions in Parkinson’s disease and Related Disorders Ljubljana, Slovenia, October 06-09, 2016, 5th Asian and Oceanian Parkinson’s Disease and Movement Disorders Congress, March 11–13, 2016, Manila, Philippines, 9th NeuroRehabilitation May 10-13 2016, Philadelphia. American Parkinson Disease Association in Arizona, National Parkinson's Foundation, Michael J. Fox Foundation for Parkinson's Research, Parkinson's Action Network, Parkinson’s UK

 

Track 5: Pathophysiology and Neuropharmacology

The most prominent pathological lesion observed in PD occurs in the basal ganglia of the brain’s extra-pyramidal system. The disease is characterized by a gradual loss of pigmented cells, mainly in the compact zone of the substantia nigra. These pigmented cells produce and store the neurotransmitter dopamine. The global prevalence of Parkinson disease is projected to grow to 2.89 million cases worldwide by 2022.

Related Conferences Parkinsons Conferences | Parkinsons 2016 | Neurology Congress | Neurology 2016

International Conference on Spine and Spinal Disorders  June 30-July 2, 2016 Valencia, Spain, 2nd International Conference on Central Nervous System Disorders and Therapeutics December 1-2 2016 Dubai, UAE, 2nd International Conference on Neuro Oncology and Brain Tumor July 21-22, 2016 Brisbane, Australia, International Conference on Autism May 5-6, 2016 Chicago, USA, 25th  Neuropharmacology Conference October 15 - 16 2015, Chicago, USA, 10th FENS Forum of Neuroscience 2016 Copenhagen, Denmark, 15th Asian Oceanian Congress on Neurology August 18-21, 2016 Kuala Lumpur, Malaysia, World Conference on Pharmacometrics August 21-24, 2016, Brisbane, Australia. American Parkinson Disease Association in Arizona, National Parkinson's Foundation, Michael J. Fox Foundation for Parkinson's Research, Parkinson's Action Network, Parkinson’s UK

 

Track 6: Diagnostic and Neuroimaging for Parkinson Disease

There is no accurate diagnosis/ test for Parkinson's disease, but it can find by using various symptoms and diagnostic tests used in combination. The most important diagnostic tool for PD is PET and DAT scans. CT, or computed tomography, uses X-rays and computers to produce images of inside the body including the brain. This test is used to look for signs of Parkinson's in the body; magnetic resonance imaging (MRI) is a test that produces very clear pictures, or images, of the human body without the use of X-rays. Instead of MRI uses a large magnet, radio waves, and a computer to produce these images.

Related Conferences Parkinsons Meetings | Movement Disorder Conferences | Neurology Conferences

International Conference on Neuro Oncology and Brain Tumor July 21-22, 2016 Brisbane, Australia, 7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery August 22-24, 2016 Vienna, Austria, 6th Neurological Conference May 19-20, 2016 San Antonio, USA,  2nd International Conference on Sleep Disorders and Medicine Conference November 28-30, 2016 Chicago, USA 20th International Congress on Parkinson’s Disease and Movement Disorders June 19-23 2016, Berlin, Germany, 4th World Parkinson Coalition, Portland September 20-23, 2016, 11th International Congress on Non-Motor Dysfunctions in Parkinson’s disease and Related Disorders Ljubljana, Slovenia, October 06-09, 2016, 5th Asian and Oceanian Parkinson’s Disease and Movement Disorders Congress, March 11–13, 2016, Manila, Philippines, Parkinson Action Network, February 29-March 2, 2016, Washington. American Parkinson Disease Association in Arizona, National Parkinson's Foundation, Michael J. Fox Foundation for Parkinson's Research, Parkinson's Action Network, Parkinson’s UK

 

Track 7: Parkinson Disease: Complications

PD is not fatal, but it can reduce longevity. The disease progresses more quickly in older patients, and may lead to severe incapacity within 10 - 20 years. The most common complication in PD are Thinking difficulties, Depression and  Blood pressure changes, emotional changes, Swallowing problems, Sleep problems and sleep disorders, Bladder problems, Constipation, Smell dysfunction, Fatigue, Pain, Sexual dysfunction and Bowel and Bladder Complications.

Related Conferences Parkinsons Meetings | Movement Disorder Conferences | Neurology Conferences

5th International Conference and Exhibition on Addiction Research and Therapy October 06-08, 2016 Florida, USA, Pediatric Neurology October 10-12, 2016 Kuala Lumpur, Malaysia, 4th International Conference on Vascular Dementia  June 30-July 2, 2016 Valencia, Spain, International Conference on Autism May 5-6, 2016 Chicago, USA, Pediatric Neurology Conference September 29-Oct 1, 2016 Valencia, Spain, XXI World Congress on Parkinson’s Disease and Related Disorders December 4-7, 2015, Nice, France, 10th Controversies in Neurology (CONy) March 17-20, 2016, Lisbon, Portugal, 9th World Congress on Neuro Rehabilitation  May 10-13, 2016, Philadelphia, United States, 10th Neurodegenerative Conditions Research and Development Conference September 2016, USA, The 2016 Alzheimer’s Disease Congress: 7–9 June 2016, London, United Kingdom. European Parkinson’s Disease Association, American Parkinson's Disease Association, International Parkinson and Movement Disorder Society, Parkinson's Association, Parkinson Alliance

 

Track 8: Managing life with Parkinson Disease

Managing Parkinson's disease is often difficult, but it's nothing you can't handle. Tips for managing the symptoms of Parkinson's disease are Exercise, Nutrition, Diet and Sleep. Living with Parkinson's disease can bring about a wide range of emotions, from the shock of diagnosing to depression, anger, frustration with physical challenges.

Related Conferences Parkinsons Meetings | Movement Disorder Conferences | Neurology Conferences

International Conference on Spine and Spinal Disorders  June 30-July 2, 2016 Valencia, Spain, 2nd International Conference on Central Nervous System Disorders and Therapeutics December 1-2 2016 Dubai, UAE, International Conference on Neuro Oncology and Brain Tumor July 21-22, 2016 Brisbane, Australia, International Conference on Autism May 5-6, 2016 Chicago, 11th  Non-Motor Dysfunctions in Parkinson`s Disease and related Disorders October 6-9, 2016, Ljubljana, Slovenia, 15th International Forum on Mood and Anxiety Disorders December 2-4, 2015, Prague, Czech Republic, 15th Asian Oceanian Congress of Neurology August 18-21, 2016 Kuala Lumpur, Malaysia, International Conference on Eating Disorders October 15-17, 2015, Alpbach, Austria, 20th Parkinson`s Disease and Movement Disorders June 2016, 10th Neurodegenerative Conditions Research and Development Conference September 2016, USA. European Parkinson’s Disease Association, American Parkinson's Disease Association, International Parkinson and Movement Disorder Society, Parkinson's Association, Parkinson Alliance

 

Track 9: Mood, cognition and psychosis in Parkinson Disease

Parkinson Disease is slow progressive neurological disorder, or disorder of the brain. It affects roughly 1.5 million Americans, more than Muscular Dystrophy and Multiple Sclerosis combined. PD is diagnosed in one out of every 100 people over the age of 60. Mood changes involve depression and/or anxiety. It has been thought that up to 50% of PD patients experience a mood disturbance during their illness. Mood disturbances in Parkinsons Disease lead to worsening of function and quality of life.

Related Conferences Parkinsons Congress | Parkinsons 2016 | Neurology Meetings | Neurology 2016

 2nd International Conference on  Depression, Anxiety and Stress Management November 3-4, 2016 Valencia, Spain, 2nd International Conference on  Epilepsy  October 24-26, 2016 Rome, Italy, 5th International Conference and Exhibition on Addiction Research and Therapy October 06-08, 2016 Florida, USA, 5thInternational Conference on Alzheimer’s Disease and Dementia  September 29-Oct 1, 2016 London, UK, 15thInternational Forum on Mood and Anxiety Disorders December 2-4, 2015, Prague, Czech Republic, 30thInternational Conference on Mood Disorders Research April, 2016, Baltimore, United States, 8th World Affective Disorders July 13-16, 2016 in Amsterdam, The Netherlands, International Conference on  Anxiety and Depression Conference March 31–April 3, 2016, Philadelphia, USA, 10th  Early Psychosis October, 20-22 2016, Milan. European Parkinson’s Disease Association, American Parkinson's Disease Association, International Parkinson and Movement Disorder Society, Parkinson's Association, Parkinson Alliance

 

Track 10: Novel Insights and Therapeutics for Parkinson Disease

Dopamine loss is the major key for pathological feature of Parkinson's disease and the subsequent of levodopa have revolutionized in the field of PD therapeutics. PD-associated mutations abrogate the apparently sequential process of mitophagy at distinct steps. The enzymatic function of the mitochondrial localized kinase PINK1 is thereby essential and promotes a fast recruitment of Parkin from its uniform distribution in the cytoplasm to damaged mitochondria. The ubiquitin ligase Parkin, in turn, is required for the attachment of ubiquitin to VDAC1. The striatal medium spiny neurons, which are normally exposed to  relatively stable at synaptic release of dopamine, become ‘sensitised’ by these erratic inputs and alter their firing pattern, which causes downstream abnormalities in  neuronal activity of the basal ganglia.

Related Conferences Parkinsons Congress | Parkinsons 2016 | Neurology Meetings | Neurology 2016

5th International Conference and Exhibition on Addiction Research and Therapy October 06-08, 2016 Florida, USA, 4th  International Conference on Vascular Dementia  June 30-July 2, 2016 Valencia, Spain, International Conference on Autism May 5-6, 2016 Chicago, USA, Pediatric Neurology Conference September 29-Oct 1, 2016 Valencia, Spain, 11th  Non-Motor Dysfunctions in Parkinson`s Disease and related Disorders October 6-9, 2016, Ljubljana, Slovenia, 15th  International Forum on Mood and Anxiety Disorders December 2-4, 2015, Prague, Czech Republic, 15th Asian Oceanian Congress on Neurology August 18-21, 2016 Kuala Lumpur, Malaysia, International Conference Eating Disorders October 15-17, 2015, Alpbach, Austria, 20th Parkinson`s Disease and Movement Disorders June 2016, 10th International Conference on Neurodegenerative September 2016, USA. Davis Phinney Foundation, Parkinson's Resource Organization, Parkinson's Disease Foundation, Austrian Parkinson Society, Northwest Parkinson's Foundation, Move4Parkinson’s

 

Track 11: Pediatric Movement Disorders

Pediatric movement disorders are relatively new and growing field of child neurology. Whereas hypokinetic disorders such as PD predominate in adults, children more commonly demonstrate hyperkinetic disorders such as tics, tremor, chorea, and dystonia. The central nervous systems typically implicated in disorders of movement are the basal ganglia (subthalamic nucleus,putamen, globus pallidus,  substantia nigra, caudate) and frontal cortex.

Related Conferences Parkinsons Congress | Parkinsons 2016 | Neurology Meetings | Neurology 2016

Pediatric Neurology Conference September 29-Oct 1, 2016 Valencia, Spain,   2nd International Conference on  Depression, Anxiety and Stress Management November 3-4, 2016 Valencia, Spain, 2nd International Conference on  Epilepsy  October 24-26, 2016 Rome, Italy, 5th International Conference and Exhibition on Addiction Research and Therapy October 06-08, 2016 Florida, USA, 20th International Congress on Parkinson’s Disease and Movement Disorders June 19-23 2016, Berlin, Germany, 4th  World Parkinson Coalition, Portland September 20-23, 2016, Parkinson Action Network, February 29-March 2, 2016, Washington, 11th International Congress on Non-Motor Dysfunctions in Parkinson’s disease and Related Disorders Ljubljana, Slovenia, October 06-09, 2016, 5th Asian and Oceania Parkinson’s Disease and Movement Disorders  Congress, March 11–13, 2016, Manila, Philippines. Davis Phinney Foundation, Parkinson's Resource Organization, Parkinson's Disease Foundation, Austrian Parkinson Society, Northwest Parkinson's Foundation, Move4Parkinson’s

 

Track 12: Non-motor complications of Parkinson Disease

Non-motor symptoms will appear throughout the course of PD, complicating the advanced phase in particular, but they are also common in the premotor phase of PD. The appearance of non-motor manifestations represents a milestone, determining a worse prognosis and less quality of life; however, they are often misdiagnosed and untreated. The spectrum of non-motor symptoms encompasses dementia, mood disorders, psychosis, sleep disorders, impulse-control disorders and autonomic dysfunctions.

Related Conferences Parkinsons Congress | Parkinsons 2016 | Neurology Meetings | Neurology 2016

7th Global Neurologists Annual Meeting on Neurology and Neuro Surgery August 22-24, 2016 Vienna, Austria, International Conference on Dual diagnosis July 21-22, 2016 Chicago, USA, International Conference on Neuro Rehabilitation  July 21-22, 2016 Brisbane, Australia, 4th International Conference on Vascular Dementia June 30-July 2, 2016 Valencia, Spain, 20th International Congress on Parkinson’s Disease and Movement Disorders, June 19-23 2016, Berlin, Germany, 4th  World Parkinson Coalition, Portland September 20-23, 2016, 5th Asian and Oceania Parkinson’s Disease and Movement Disorders Congress March 11–13, 2016, Manila, Philippines, 11thInternational Congress on Non-Motor Dysfunctions in Parkinson’s disease and Related Disorders Ljubljana, Slovenia, October 06-09, 2016,  9th World Congress on Neuro Rehabilitation May 10-13 2016, Philadelphia. North Country Coalition for Parkinson's and Movement Disorders, The Cure Parkinson's Trust, Austrian Parkinson Society, Alzheimer’s Association,  Alzheimer’s Drug Discovery Foundation-Canada, Alzheimer’s Research UK

Omics Group Conference Series would like to welcome all the Directors, Heads, Deans, Professors, Scientists, Researchers, Doctors and students of neurology department  for “2nd  International conference on Parkinson's Disease and Movement Disorders” on December 05-07, 2016 at Phoenix, USA, The theme of Parkinson conference is based on “Leading Innovation and Remedial Insight of Parkinsons Disease”. This conference is mainly focus will focus the latest and exciting innovations in every area of parkinsons research, and it will offer a unique opportunity for investigators from all over the world to meet, network, and perceive new scientific interactions.

Parkinson’s disease is one of the commonest neurological conditions. It is estimated to affect up to 160 per 100,000 of the general population with an annual incidence of 15–20 per 100,000. Many population studies have shown the rising prevalence with age (up to 2% of the population aged 80 and over). Around 1 in 7 cases are diagnosed below the age of 60 years. The costs of treatment have been estimated at between £560,000 and £1.6 million per 100,000 of the population.

In USA a 3-year prospective study of the economic cost of PD was performed in 2006. The average annual cost per patient was estimated at $12,091, of which 55,9% accounted for direct costs. Drugs took up the major share of direct costs, $5,763 per year. Indirect costs accounted for $4,851 per patient per year. Within this, 76% of the costs were related to nursing care and the loss of productivity.

Latest Parkinson News revealed: Fetal Cells can cure the Parkinson Disease by injecting into man's brain.

Why to attend???

Conduct demonstrations, workshops, and symposiums, distribute information, meet with current and potential national & international experts, make a splash with a new product line, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Neurodegenerative fields are hallmarks of this conference.

It is our greatest pleasure to welcome you to the 2nd International Conference on Parkinson’s Disease and Movement Disorders (Parkinsons-2016), that aims at bringing together the professors, physician researchers, surgeons, health educators, nurse researchers and students in all areas of Parkinson Disease and to provide an international forum for the dissemination of original research results, new ideas, innovations and practical development experiences which concentrate on both theory and practices. Our aim is to aggregate researchers, academicians and scientists from the Parkinson community and to create an avenue towards robust exchange of information on latest technological advances, new scientific achievements, and the effectiveness of various regulatory programs towards Parkinson Disease.

Target Audience:

Directors, Neurologist, Neurosurgeons, Psychiatrist, Surgeon, Head of department, Industries, Business delegates, Clinicians, Community Members, Professors and Students from Academia in the research of Parkinson disease and Movement Disorders.

About the Conference:

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Parkinsons-2016, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Parkinsons-2016 organizing committee look forward to meeting you in Phoenix, USA.

For more details please visit- http://parkinsons.conferenceseries.com/

Importance and Scope:

2nd International Conference on Parkinson’s Disease and Movement disorders is a unique forum to bring together worldwide distinguished academics in the field of neuroscience and neurology, researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies.

Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Parkinson Disease.

Conferences, National symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about Parkinson Disease and its allied areas.

Overview of Parkinson’s disease, including etiology, pathophysiology, motor and non-motor symptoms, and quality of life.

Why Phoenix?

Parkinsons 2016 is going to be held at Phoenix it is the capital and largest city of the state of Arizona. With 1,445,632 people (as of the 2010 U.S. Census), Phoenix is the most populous state capital in the United States, as well as the 6th most populous city nationwide. The city is the 13th largest metro area by population in the United States, with approximately 4.3 million people in 2010.  Located in the north-eastern reaches of the Sonoran Desert, Greater Phoenix is the corporate headquarters of six Fortune 500 companies. Phoenix encompasses 517 square miles of total area out of which 516 square miles are composed of land and the rest water. The city is situated at about 1086 feet above the sea level.

Parkinson’s disease is the 14th leading cause of death in the United States is estimated to be as many as 1.5 million. Approximately 60,000 Americans are newly diagnosed each year. The average age of onset of the disease is 60, with incidence increasing significantly with age. About 5 percent to 10 percent of people have “early-onset” disease that begins as early as age 50 or even earlier.  NINDS funded approximately $90 million out of a total of $135 million in NIH-supported PD research in USA. There are around 20 Universities which are working in the field of Parkinson’s disease. Around 500 neurologist, psychiatrist and neurosurgeons are working exclusively on Parkinson’s disease in Phoenix.

Conference Highlights:

  •          Epidemiology of Parkinsons disease
  •          Neuromuscular Disorders
  •          Neurocognitive Disorders
  •          Risk factors for Parkinsons disease
  •          Pathophysiology and Neuropharmacology
  •          Diagnostic and Neuroimaging for Parkinson Disease
  •          Parkinson Disease: Complications
  •          Managing life with Parkinson Disease
  •          Mood, cognition and psychosis in Parkinson Disease
  •          Novel Insights and Therapeutics for Parkinson Disease
  •          Pediatric Movement Disorders
  •          Non-motor complications of Parkinson Disease

Why to attend???

Conduct demonstrations, workshops, and symposiums, distribute information, meet with current and potential national & international experts, make a splash with a new product line, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Neurodegenerative fields are hallmarks of this conference.

It is our greatest pleasure to welcome you to the 2nd International Conference on Parkinson’s Disease and Movement Disorders (Parkinsons-2016), that aims at bringing together the professors, physician researchers, surgeons, health educators, nurse researchers and students in all areas of Parkinson Disease and to provide an international forum for the dissemination of original research results, new ideas, innovations and practical development experiences which concentrate on both theory and practices. Our aim is to aggregate researchers, academicians and scientists from the Parkinson community and to create an avenue towards robust exchange of information on latest technological advances, new scientific achievements, and the effectiveness of various regulatory programs towards Parkinson Disease.

A Unique Opportunity for Advertisers and Sponsors at this International event:

http://parkinsons.conferenceseries.com/sponsors.php

Major Associations around the Globe

  • National Parkinson Foundation
  • American Parkinson Disease Association (APDA)
  • Parkinson’s disease Foundation
  • Movement Disorder Society of Australia
  • Parkinson's Unity Walk
  • Movement Disorder Society of Japan
  • Moroccan Neurological Society Movement Disorders Group
  • Italian Society for the Study of Parkinson Disease, Extrapyramidal Diseases and Dementia
  • Ecuador Movement Disorders Group
  • Austrian Parkinson's Disease Society
  • Danish Movement Disorder Society

Around 15 associations of Parkinson Disease are there in USA

  • Parkinson Association of the Rockies
  • Brian Grant Foundation
  • The Michael J. Fox Foundation
  • The Foundation for Mitochondrial Medicine
  • The International Parkinson and Movement Disorder Society
  • Parkinson Alliance
  • Parkinson's Action Network (PAN)
  • The Parkinson's Institute and Clinical Center
  • Bachmann-Strauss Dystonia & Parkinson Foundation
  • Parkinson's Resource Organization
  • Davis Phinney Foundation

Target Audience:

Directors, neurologist, neurosurgeons, psychiatrist, Surgeon, head of department, Professors and Students from Academia in the research of Parkinson disease and Movement Disorders.

Target Audience:

Academia       60%

Industry         30%

Others             10%

Top universities 500 globally working in the field of Parkinson Disease

  • University of Bath
  • The University of Queensland
  • University of Bristol
  • University of Cambridge
  • The Imperial College of Science and Medicine
  • Duke University
  • University of Milan
  • Karolinska Institute
  • University of Hamburg
  • The University of Edinburgh
  • University of Munich
  • University of Rochester
  • University of Zurich
  • Leiden University
  • University of Bristol
  • University of Helsinki
  • Uppsala University
  • University of Freiburg
  • University of Frankfurt

Top universities in USA working in the field of Parkinson Disease

  • University of California
  • University of Kansas Medical Center
  • University of South Alabama 
  • University of Florida
  • University of Miami 
  • Georgia Health Sciences University
  • Emory University
  • Northwestern University Movement Disorders Center
  • Johns Hopkins Parkinson's Disease&Movement Disorders Center
  • New York University Langone Medical Center
  • University of Rochester Medical Center
  • Duke University Medical Center
  • University of North Carolina
  • Oregon Health & Science University Parkinson Center of Oregon
  • University of Pennsylvania
  • Vanderbilt University Medical Center
  • Baylor College of Medicine

Top Universities in Phoenix

  • University of Arizona
  • Arizona State University
  • Northern Arizona University
  • Grand Canyon University
  • Prescott College
  • Collins CollegeWestern International University
  • Arizona Christian University
  • National Paralegal College
  • Ottawa University
  • DeVry University-Arizona

Top Hospitals in Phoenix

  • Northwestern Memorial Hospital
  • Rush University Medical Center
  • Northwestern Medicine Central DuPage Hospital
  • St. Alexius Medical Center
  • NorthShore Evanston Hospital
  • Alexian Brothers Medical Center
  • Adventist Hinsdale Hospital

Approximately 17,254 Hospitals in the World

Number of Hospitals in United States: 6,410

Approximately 200 Hospitals in Phoenix

Industries Associated with Parkinson Research

  • Biogen Idec
  • Dainippon Sumitomo Pharma
  • BioSante Pharmaceuticals
  • GlaxoSmithKline (GSK)
  • Boehringer Ingelheim

Market Analysis

The US will have the largest PD therapeutics market share of 44% by 2022, expanding from 32% in 2012. This will be followed by Japan, Brazil and Germany, with respective shares of 13%, 11% and 10%.

Market Growth of Conference

The Parkinson Disease market was worth USD 3.6 billion in 2012 and is expected to reach USD 5.3 billion in 2022, growing at a CAGR of 4% from 2012 to 2022.

References

http://colleges.usnews.rankingsandreviews.com/best-colleges/seattle-university-3790

http://www.healthcare.globaldata.com/media-center/press-releases/pharmaceuticals/global-parkinsons-disease-therapeutics-market-value-to-reach-53-billion-by-2022-as-current-pipeline-addresses-advanced-patients-needs-says-globaldata

http://www.ninds.nih.gov/disorders/parkinsons_disease/org_parkinsons_disease.htm

https://en.wikipedia.org/wiki/Parkinson's_disease

http://health.usnews.com/best-hospitals/area/wa

Parkinsons-2015

OMICS International takes a great pride in announcing the commencement of International Conference on Parkinson’s disease and Movement Disorders-2015 during August 11-13, 2015. Parkinsons-2015 has received a benevolent response from all over the world. This has been conducted with the aim and the categorical intent of promoting the developments of new perceptions and ideas for exploring the high level of knowledge reached by scientific community on Parkinsons and Disorders. The extremely illustrious conference hosted by OMICS International was marked with the attendance of young and brilliant researchers, business delegates and talented student communities.

The conference was organized around the theme “Leading Innovations and Remedial Insights into the Parkinsons disease”. The event implanted a firm relation of upcoming strategies in the field of Parkinson’s disease with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

This conference brought together Leading World Parkinsons physicians, Neurosurgeons, Neuroradiologists, Clinicians, Professors, Care Specialists, Students and other professionals in which many issues in Parkinsons field were discussed in depth to provide up-to-date information to the world. On the other hand, the meeting provided an opportunity for an open and animated sharing of ideas and experiences.

The conference witnessed an amalgamation of peerless speakers, who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Parkinson’s disease. The eminent personalities at the conference were Kjell Fuxe, Karolinska Institutet, SwedenRobert Ledeen, New Jersey Medical School, USAGeorge Stoica, Texas A&M University, USAMichael Ugrumov, RAS Center for Brain Research, Russia, Ekaterina Rogaeva, University of Toronto, Canada, Dasiel O Borroto Escuela, Karolinska Institutet, Sweden.

OMICS International offers its heartfelt appreciation to all the Organizing Committee Members, Chairs and Co-chairs, Speakers, Students, Media Partners and Editorial Board Members of Journal of Alzheimer Disease & Parkinsonism, Journal of Depression and Anxiety and Journal of Neurological Disorders who supported the conference in every aspect for the awe-inspiring exhibition at the venue.

We once again thank you all for the enormous exquisite response. This inspires us to continue organizing events and conferences for furthering the Clinical Research. OMICS therefore, is glad to announce its "2nd International Conference on Parkinson’s Disease and Movement Disorders" which will be held during December 05-07, 2016 Phoenix, USA.

Mark your calendars for the upcoming extravaganza; we are hoping to see you soon!    


Past Reports  Gallery  

Neuro-2014

The 3rd International Conference & Exhibition on Neurology and Therapeutics organized by OMICS Group International was successfully held at Hilton Philadelphia Airport, Philadelphia, USA during September 08-10, 2014. The conference was organized with the theme “Novel Therapies in Neurosciences and Neurological Disorders"

The conference was marked with the presence of renowned scientists, talented young researchers, students and business delegates representing more than 20 different countries ultimately driving the event into the path of success.

OMICS Group also took the privilege of felicitating Neurology-2014 Organizing Committee, Editorial Board Members of Journal of Neurology & Neurophysiology , Journal of Brain Disorders & Therapy, Journal of Neurological Disorders and Autism- Open Access, Keynote Speakers,  Chair and Co-Chairs whose support led the conference into the path of excellence.

We are also obliged to various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums.

OMICS Group would like to convey a warm gratitude to all the Honorable guests of Neurology-2014. The highlights of the conference were its educative and effectual keynote lectures by:

Simon Kaja, University of Missouri, USA

James Nussbaum, ProHealth & Fitness PT OT, USA

Marie Trad, Quintiles, France

Jacqueline Sidman, The Sidman Institute, USA

All the above mentioned keynote speakers gave their energetic and fruitful contributions at Neurology-2014All the keynote sessions, speaker sessions, Special session,workshop, symposium, and student poster presentations focused on the specific theme of the conference “Novel Therapies in Neurosciences and Neurological Disorders” The theme of the conference spurred the sessions and provided an insightful and excellent knowledge on the upcoming advances, research, and technology in neurology therapeutics.

On day 2, Jacqueline Sidman conducted a Workshop on “Unravelling defense mechanisms: How the subconscious mind releases early painful memories in order to heal physical, behavioral and emotional problems.” On day 2, Special session on “CNS drug development perspectives for young neurologists” was taken up by Marie Trad, QuintilesFrance. Both the workshop and the special session discussed the major breakthroughs and developments in the field of neurology.

On day 3 symposium on “Stem cells for Neurological Disorders” by Guang-Xian Zhang, Thomas Jefferson University, USA discussed the Novel Therapies in Neurology.

The conference also provided an exclusive environment to the students for their development of research and gave them an opportunity to raise the profile of their research by poster presentations. Best poster awards were also given by the student council.

All accepted abstracts have been indexed in Journal of Neurology and Neurophysiology as a special issue.

Our special gratitude to our Exhibitor Proove  Biosciences and Media Partners ProHealth & Fitness, USA; The Sidman Institute, USA; Royal society of chemistry, USA; After the immense and grand response received for the International Conference on Neurology and Therapeutics, OMICS Group International proudly announces the commencement of its "4thInternational Conference & Exhibition on Neurology and Therapeutics” to be held during July 27-29, 2015  at Naples, Italy.

 


Past Reports  Gallery  

Neuro-2013
On June 17-19, 2013 OMICS Group hosted the 2nd International Conference and Exhibition on Neurology & Therapeutics in Hilton Chicago/Northbrook, Chicago, USA. OMICS feels proud to present to you the outcome and result of this conference.

The conference started with an opening ceremony followed by the keynote sessions. The keynote speakers for the session were: Ahmad Salehi, Stanford University, USA, Giulio M. Pasinetti, Mount Sinai Hospital, USA, Guang-Xian Zhang, Thomas Jefferson University, USA, Simon Kaja, University of Missouri, USA, and Moses Rodriguez Mayo Clinic, USA.

All the keynote sessions, other sessions, workshops, symposium, and student poster presentations focused on the specific theme of the conference “Emerging Trends in Neurological Therapeutics.” The theme roofed a broad range of topics including: The Therapeutic Aspects of Molecular and Cellular Neuroscience, Somatic and Autonomic Nervous System, Neurodegenerative and Movement Disorders, Novel Research In Neurological Medicine and Trauma, Application of Computational Neuroscience, Neurological Assessment Systems, Neuro-Oncology, Neurology and Current Research, Nanotechnology and Biomarkers: Future Prospect for Drug Discovery, Case studies of Different Neurological Disorders, Biofeedback and Neuromarketing. The theme of the conference spurred the sessions and provided an insightful and excellent knowledge on the upcoming advances, research, and technology in neurology therapeutics.

On day 1, Giulio M. Pasinetti conducted a symposium on “Development of natural compound for treatment of neurodegenerative disorders.” OMICS gave him an award for his excellence in academic and research activities. On day 2, a workshop on “Neuro Immunology” was taken up by Guang-Xian Zhang, Thomas Jefferson University, USA. Both the workshop and the symposium discussed the major breakthroughs and developments in the field of neurology.

The conference also provided an exclusive environment to the students for their development of research and gave them an opportunity to raise the profile of their research by poster presentations. Best poster awards were also given by the student council.

The conference was an unforgettable event that left a lasting impression on everyone. OMICS is grateful to all the organizing committee members, editorial board members of OMICS journals, keynote speakers, other speakers, students, sponsors, exhibitors, media partners and all the attendees.

OMICS is confident of delivering the same success and worldwide participation in the forthcoming conferences.


Past Reports  Gallery  

Neuro-2012
The International Conference & Exhibition on Neurology & Therapeutics, hosted by theOMICS Group was held on May 14-16, 2012 in Embassy Suites Las Vegas, USA. Generous response and active participation was received from the Editorial Board Members of OMICS Group Journals as well as from neurologists, researchers and leaders from pharma, government organizations who made this conference as one of most successful and productive events in 2012 from OMICS Group

The conference was carried out through various sessions, in which the discussions were held on the following scientific tracks

  • Alzheimer's Disease
  • Neural Stem Cells and Gene or Cell Therapy
  • Diagnosis and Genetic Testing for Neurological Disorders
  • Neuroimmunology
  • Neuromics & Human Brain proteome
  • Perspectives in Neurology Research
  • Neurorehabilitation
  • Epilepsy
  • Current trends in Neurophysiology
  • Cerebral CSF Flow Studies
  • Diagnosis for cerebral infections
  • Clinical Neurophysiology & Electrophysiology

The conference was initiated with a series of keynote addresses by well-known speakers Dr. C. David James from University of California, San Francisco, USA, Dr. Asim Mahmoodfrom Henry Ford Hospital, USA, Dr. Ahmad Salehi from Stanford Medical School, USA, Dr. Abha Chauhan from NYS Institute for Basic Research in Developmental Disabilities, USA.

All the above mentioned keynote speakers gave their energetic and fruitful contributions atNeuro-2012.

All accepted abstracts have been indexed in OMICS Group Journal of Neurology & Neurophysiology as a special issue

We are also obliged to various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums. Our sincere thanks to Organizing Committee Members for their gracious presence, support and assistance towards Neuro-2012, and with their unique feedback, OMICS Group would like to announce the "2nd International Conference and Exhibition on Neurology & Therapeutics" to be held at Chicago, USA on April 15-17, 2013. 


Past Reports  Gallery  

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date December 05-07, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Media Partners

Conferenceseries Destinations


Mail us at

Drop us an email for Program enquiry.
parkinsons@conferenceseries.net
Sponsors / Exhibiting / Advertising.
parkinsons@conferenceseries.com
General Queries.
parkinsons@neuroconferences.com

View Proceedings of Previous Conferences

Parkinsons 2015
Neurology 2015
Neurology 2014
Dementia 2015
Authorization Policy

By registering for the conference you grant permission to Conferenceseries LLC to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or videotaping during any session is prohibited. Contact us for any queries.